Latest Board Changes News

Page 2 of 39
Janus Electric Holdings reported a 46% increase in net loss to $4.93 million for the half-year ended December 2025, driven by rising costs despite a 33% revenue boost. The company faces funding uncertainties as it pursues key investments and operational scale-up.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Skin Elements Limited reported a $4.01 million loss for the half-year ending December 2025, alongside a 41% revenue drop, while securing $2.5 million in fresh capital to advance its proprietary SE Formula biotechnology products.
Ada Torres
Ada Torres
27 Feb 2026
Energy Technologies Limited reported a $5.63 million net loss for the half-year ending December 2025, with revenue down 53% as the company restructures and refocuses on renewable energy markets. Significant debt refinancing and board changes mark a critical phase for the industrial cable manufacturer.
Victor Sage
Victor Sage
27 Feb 2026
De.mem Limited reported a 20% increase in revenue to $29.9 million for FY2025, alongside a reduced net loss and its first full-year positive adjusted EBITDA. The company also completed the acquisition of Core Chemicals, expanding its specialty chemicals footprint in the gold mining sector.
Victor Sage
Victor Sage
27 Feb 2026
Tribeca Global Natural Resources Limited reported a remarkable turnaround with a $69.5 million net profit for the half-year ended December 2025, alongside a fully franked dividend declaration. The company’s net tangible asset per share more than doubled, reflecting strong commodity market dynamics and strategic investment execution.
Claire Turing
Claire Turing
26 Feb 2026
Aland Equity Group reported a sharp revenue decline and an 85% increase in losses for the half-year ending December 2025, while completing a major capital raise and reshuffling its board.
Claire Turing
Claire Turing
26 Feb 2026
Anatara Lifesciences reports a significantly reduced net loss for H1 FY2026, driven by promising pre-clinical results in its anti-obesity program and a successful $1.2 million capital raise. The company also highlights positive Phase II trial outcomes for its gastrointestinal health product GaRP.
Ada Torres
Ada Torres
25 Feb 2026
PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.
Ada Torres
Ada Torres
23 Feb 2026
Apiam Animal Health has officially become a wholly owned subsidiary of Adamantem Capital's entities following a scheme of arrangement, with shareholders receiving a special dividend and a mix of cash and shares. The company will soon be delisted from the ASX.
Ada Torres
Ada Torres
23 Feb 2026
White Cliff Minerals has agreed to sell its Great Bear Project in Canada for A$5.8 million, while announcing key board appointments to support its next growth phase.
Maxwell Dee
Maxwell Dee
23 Feb 2026
PVW Resources has completed its acquisition of Southern Prospecting, gaining full ownership of the Cobb Creek Project in Nevada with a historical gold estimate of 173,000 ounces. The move marks a significant shift towards North American precious metals exploration.
Maxwell Dee
Maxwell Dee
23 Feb 2026
BSA Limited reported an 84% plunge in revenue for the half-year ending December 2025, driven by lost contracts and reduced volumes, yet managed a $6.3 million profit amid restructuring and cost controls. Significant board changes signal a strategic reset as the company navigates uncertain waters.
Victor Sage
Victor Sage
20 Feb 2026